Clinical Trial Update: PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

Phase IIa trial results for PA-824 (pretomanid) evaluating early bactericidal activity in pulmonary tuberculosis; the study completed and results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Pretomanid (PA-824) (pretomanid)

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04